
Microsoft co-founder and former CEO Bill Gates told CNBC Wednesday morning, October 14, he had been naive about the government scrutiny that comes with getting large when he was running Microsoft.
“Whenever you get to be a super valuable company, affecting the way people communicate and even political discourse being mediated through your system and higher percentage of commerce through your system, you’re going to expect a lot of government attention,” Gates said in the “Squawk Box” interview.
Last week, the House Judiciary subcommittee on antitrust released a report concluding that Amazon, Apple, Facebook, and Google hold monopoly power.
“I was naive at Microsoft and didn’t realize that our success would lead to government attention,” Gates said, referring to Microsoft’s antitrust challenges from over 20 years ago. “And so I made some mistakes , you know, just saying, ‘Hey, I never go to Washington, DC’ And now I don’t think, you know, that naivete is there.”
Gates stepped down as Microsoft CEO in the middle of the US Justice Department’s antitrust case, which charged the company had tried to monopolize the web browser market when it bundled Internet Explorer with Windows. The company settled with the DOJ in 2001.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas